Literature DB >> 4706292

Foetal antigens and cancer.

J E Castro, E M Lance, P B Medawar, J Zanelli, R Hunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4706292     DOI: 10.1038/243225a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Radiation-induced lymphoblastic lymphomas/leukemias and sarcomas of mice express conserved, immunogenic 44-kilodalton oncofetal antigen.

Authors:  J H Coggin; S D Rohrer; E D Leinbach; R B Hester; P I Liu; L S Heath
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Ulcerative colitis. Animal model: immunoreactive inflammation in fetal colon implants in syngeneic adult rats.

Authors:  R C Nairn; R Savvas; G Hocking; M Kovala; J M Rolland
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

3.  Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.

Authors:  M Gubersky; D M Thomson; M Lajzerowicz
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Response of tumour-related and normal lymphocytes to antigens on fibroblasts from embryos of varying age.

Authors:  R M Gorczynski
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

5.  Comparison of antigenicity of hepatoma cells, normal liver cells, foetal liver cells and chemically damaged liver cells in guinea-pigs immunized with hepatomata using the macrophage migration inhibition test.

Authors:  H N Desai; M M Dale
Journal:  Br J Cancer       Date:  1974-08       Impact factor: 7.640

6.  Embryonic antigens and growth of murine fibrosarcomata.

Authors:  S Ménard; M I Colnaghi; G Della Porta
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

7.  Inhibition of cell proliferation rather than of cell lysis as a measure of immune reactivity in embryo-antigen-challenged mice.

Authors:  R M Gorczynski; S MacRae
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.